The BioInnovation Institute & Science Translational Medicine Prize aims to recognize researchers who have developed innovative advances with translational potential to impact women’s health globally.
Contributions within any area of women’s health* will be considered. These may cover work in areas of female-specific conditions including maternal health and chronic gynecological diseases, reproductive health including contraception and infertility affecting all persons, or elucidation of sex- and gender-specific approaches to conditions that affect women differently or disproportionately.
MVA member BioInnovation Institute & Science encourage researchers who may have made significant advances in addressing questions in these fields at the intersection of translational research and clinical applications, or who are developing new drugs, diagnostic approaches, medical devices, or healthcare technologies, to apply. Researchers who have advanced development of new solutions that can be readily deployed in low- and middle-income countries are encouraged to apply.
The Prize is awarded for outstanding research performed by the applicant and as described in a 1,000-word essay.
The Grand Prize winner will be awarded a cash prize of USD 25,000 and will be provided reasonable travel and accommodation for the awards ceremony, if applicable. They will also receive a 5-year digital subscription to Science Translational Medicine and have their winning essay published online in Science Translational Medicine.
Deadline for Submissions: November 1, 2025
Read more about rules of eligibility and how to enter on Science Magazines webpage